BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17439831)

  • 1. A new automated screening assay for the diagnosis of von Willebrand disease.
    Salem RO; Van Cott EM
    Am J Clin Pathol; 2007 May; 127(5):730-5. PubMed ID: 17439831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity.
    Lasne D; Dey C; Dautzenberg MD; Cherqaoui Z; Monge F; Aouba A; Torchet MF; Geloen D; Landais P; Rothschild C
    Haemophilia; 2012 May; 18(3):e158-63. PubMed ID: 21951857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease.
    De Vleeschauwer A; Devreese K
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):353-8. PubMed ID: 16788311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test.
    Mori F; Rossi P; Nardini I; Gambelli D; Farina C
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):221-8. PubMed ID: 20179578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.
    Cabrera N; Moret A; Caunedo P; Cid AR; Vila V; España F; Aznar JA
    Haemophilia; 2013 Nov; 19(6):920-5. PubMed ID: 23730809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an automated von Willebrand factor activity assay in von Willebrand disease.
    Trossaërt M; Ternisien C; Lefrancois A; Llopis L; Goudemand J; Sigaud M; Fouassier M; Caron C
    Clin Appl Thromb Hemost; 2011; 17(6):E25-9. PubMed ID: 20724302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.
    Budde U; Pieconka A; Will K; Schneppenheim R
    Semin Thromb Hemost; 2006 Jul; 32(5):514-21. PubMed ID: 16862525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use.
    Murdock PJ; Woodhams BJ; Matthews KB; Pasi KJ; Goodall AH
    Thromb Haemost; 1997 Oct; 78(4):1272-7. PubMed ID: 9364997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of von Willebrand factor activity: evaluation of the HaemosIL assay in comparison with established procedures.
    Sucker C; Senft B; Scharf RE; Zotz RB
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):305-10. PubMed ID: 16959683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of von Willebrand disorder and identification of qualitative von Willebrand factor defects. Direct comparison of commercial ELISA-based von Willebrand factor activity options.
    Favaloro EJ
    Am J Clin Pathol; 2000 Oct; 114(4):608-18. PubMed ID: 11026108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
    Rodgers SE; Lerda NV; Favaloro EJ; Duncan EM; Casey GJ; Quinn DM; Hertzberg M; Lloyd JV
    Am J Clin Pathol; 2002 Aug; 118(2):269-76. PubMed ID: 12162689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000).
    Lattuada A; Preda L; Sacchi E; Gallo L; Federici AB; Rossi E
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):505-11. PubMed ID: 15311161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance.
    de Maistre E; Volot F; Mourey G; Aho LS; Ternisien C; Briquel ME; Bertrand MA; Tardy B; Frotscher B; Nguyen P; Dumont L; Vandroux D; Hézard N; Trossaërt M
    Thromb Haemost; 2014 Oct; 112(4):825-30. PubMed ID: 25103956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder.
    Favaloro EJ
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):299-319. PubMed ID: 11686101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.
    Verfaillie CJ; De Witte E; Devreese KM
    Int J Lab Hematol; 2013 Oct; 35(5):555-65. PubMed ID: 23551532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.